A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia

NCT01114139 PHASE3 COMPLETED Results posted

To evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared with placebo for the treatment of iron deficiency anemia (IDA).

Details

Lead sponsor	AMAG Pharmaceuticals, Inc.
Phase	PHASE3
Status	COMPLETED
Enrolment	812
Start date	Sat Jun 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Oct 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Iron Deficiency Anemia

Interventions

• Ferumoxytol
• Placebo

Countries

India, Hungary, Poland, Canada, United States, Latvia